3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Multiple Myeloma
3
Leukemia, Myeloid, Acute
3
Recurrence
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplasms
2
Myelodysplastic Syndromes
2
Lymphoma, Non-Hodgkin
2
Lymphoma
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Burkitt Lymphoma
2
Waldenstrom Macroglobulinemia
1
Urologic Neoplasms
1
Thyroid Neoplasms
1
Thrombocythemia, Essential
1
Soft Tissue Neoplasms
1
Sezary Syndrome
1
Sarcoma
1
Rhabdomyosarcoma, Embryonal
1
Rhabdomyosarcoma, Alveolar
1
Rhabdomyosarcoma
1
Pseudomyxoma Peritonei
1
Primary Myelofibrosis
1
Precancerous Conditions
1
Polycythemia Vera
1
Pharyngeal Neoplasms
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Neurofibrosarcoma
1
Neurofibromatosis 2
1
Neurofibromatosis 1
1
Interventions
X-Rays
5
Phantoms, Imaging
5
Nuclear Medicine Department, Hospital
5
Magnetic Resonance Spectroscopy
5
Specimen Handling
4
Biopsy
4
ulixertinib
2
tipifarnib
2
selpercatinib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
Cyclophosphamide
2
tazemetostat
1
talazoparib
1
palbociclib
1
olaparib
1
irinotecan sucrosofate
1
fludarabine phosphate
1
fludarabine
1
Vincristine
1
Vinblastine
1
Vemurafenib
1
Topotecan
1
Temozolomide
1
Pharmacogenomic Variants
1
Methotrexate
1
Mesna
1
LY3023414
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Rhabdoid Tumor
×
Sirolimus
×
30 days
×
Clear all
No trials found.